Condition: Articular Cartilage Disorder · Degeneration; Articular Cartilage · Chronic Cartilage Injury · Sponsor: ISTO Technologies, Inc.
ISTO Technologies, Inc. is proposing a clinical study with 225 subjects, to establish the safety and efficacy of the Neocartilage Implant for the treatment of ICRS Grade 3 and 4 articular cartilage lesions of the knee compared to microfracture treatment.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Kerlan Jobe Orthopaedic Clinic | Los Angeles, California, United States | — |
| Santa Monica Orthopaedic & Sports Medicine Group | Santa Monica, California, United States | — |
| Rush University Medical Center | Chicago, Illinois, United States | — |
| Hospital for Special Surgery -Sports Medicine and Shoulder Service | New York, New York, United States | — |
| Insall Scott Kelly Institute for Orthopaedics & Sports Medicine | New York, New York, United States | — |
| Cleveland Clinic | Cleveland, Ohio, United States | — |
| The Ohio State University Sports Medicine Center | Columbus, Ohio, United States | — |
| The Hawkins Foundation | Greenville, South Carolina, United States | — |
| The Methodist Hospital Research Institute | Houston, Texas, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01400607